Denarda D. Laniti
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rethinking ovarian cancer III: the past decade and future directions.
Journal: Nature reviews. Cancer
Published: February 23, 2026
State-of-the art in emerging therapeutics for ovarian cancer therapy.
Journal: Gynecologic oncology
Published: May 22, 2025
Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing.
Journal: Molecular therapy. Oncology
Published: October 01, 2024
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach.
Journal: Nature reviews. Clinical oncology
Published: August 12, 2024
Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 30, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Journal: Science immunology
Published: February 02, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy.
Journal: Nature biotechnology
Published: December 04, 2023
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity.
Journal: Nature
Published: September 01, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026